Klinikum rechts der Isar der TU München
Munich 81675
2 studies enrolling now · 5 studies all time
What they study most
Parkinson Disease, Parkinson's Disease, Refractory Diffuse Large B-Cell Lymphoma, Relapsed, Diffuse Large B-cell Lymphoma, Stroke, Acute
Studies at this site
- A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease — Recruiting now
- WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment) — Recruiting now
- Open-label Trial in Parkinson's Disease (PD) — Completed
- Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3) — Completed
- Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05) — Completed